Subsequent validation of HDAC8 inhibitor and AZD-7762 combination in PDO, mouse xenograft, and PDX models showed high tumor suppression activity with a favorable tolerability profile (Figure 8 and Supplemental Figure 11). Here, HDAC8 is linked to neoplasm.